SGLT2 Inhibitors Lower Risk of Alzheimer's and Parkinson's Disease The lessons to take away from the fact that therapies for type 2 diabetes lower risk of age-related disease in diabetic patient populations are much the same as the lessons to take away from the fact that weight loss drugs produce a reduction in age-related disease. Firstly the diabetic metabolism is harmful to the degree that is remains poorly controlled, and secondly excess weight is harmful. These lessons may have little relevance to the aging of thin, physically fit people, and diabetes-associated metabolic processes may not be the most important area of focus when it comes to the aging of thin, physically fit people. The retrospective study looked at people with type 2 diabetes who started diabetes medication from 2014 to 2019 in South Korea. […]
https://www.fightaging.org/arc....hives/2024/09/sglt2-